These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 23494564)

  • 1. Synergistic interaction of β-galactosyl-pyrrolidinyl diazeniumdiolate with cisplatin against three tumor cells.
    Deng L; Zhang E; Chen C
    Arch Pharm Res; 2013 May; 36(5):619-25. PubMed ID: 23494564
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A glycosylated nitric oxide donor, beta-Gal-NONOate, and its site-specific antitumor activity.
    Chen C; Shi Y; Li S; Qi Q; Gu L; Song J; Wang PG
    Arch Pharm (Weinheim); 2006 Jul; 339(7):366-71. PubMed ID: 16783837
    [TBL] [Abstract][Full Text] [Related]  

  • 3. β-galactosyl-pyrrolidinyl diazeniumdiolate: an efficient tool to investigate nitric oxide functions on promoting cell death.
    Chen C; Zhang E
    Appl Microbiol Biotechnol; 2013 Aug; 97(16):7377-85. PubMed ID: 23801048
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Delivery of nitric oxide released from beta-Gal-NONOate activation by beta-galactosidase and its activity against Escherichia coli.
    Chen C; Shi YQ; Song J; Qi QS; Gu L; Wang PG
    Biol Pharm Bull; 2006 Jun; 29(6):1239-41. PubMed ID: 16755024
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cationic liposome-mediated nitric oxide synthase gene therapy enhances the antitumor effects of cisplatin in lung cancer.
    Ye S; Yang W; Wang Y; Ou W; Ma Q; Yu C; Ren J; Zhong G; Shi H; Yuan Z; Su X; Zhu W
    Int J Mol Med; 2013 Jan; 31(1):33-42. PubMed ID: 23128378
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antitumor activity of a new platinum(II) complex with low nephrotoxicity and genotoxicity.
    Marzano C; Bettio F; Baccichetti F; Trevisan A; Giovagnini L; Fregona D
    Chem Biol Interact; 2004 Jun; 148(1-2):37-48. PubMed ID: 15223355
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Superior antitumor efficiency of cisplatin-loaded nanoparticles by intratumoral delivery with decreased tumor metabolism rate.
    Li X; Li R; Qian X; Ding Y; Tu Y; Guo R; Hu Y; Jiang X; Guo W; Liu B
    Eur J Pharm Biopharm; 2008 Nov; 70(3):726-34. PubMed ID: 18634874
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeted diazeniumdiolates: localized nitric oxide release from glioma-specific peptides and proteins.
    Safdar S; Taite LJ
    Int J Pharm; 2012 Jan; 422(1-2):264-70. PubMed ID: 22101282
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhancement of 5-fluorouracil cytotoxicity by cisplatin in brain tumour cell lines.
    Mineura K; Kowada M
    Cell Biol Int; 1996 May; 20(5):355-7. PubMed ID: 8688852
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synergistic antitumor activity of TRAIL combined with chemotherapeutic agents in A549 cell lines in vitro and in vivo.
    Fan QL; Zou WY; Song LH; Wei W
    Cancer Chemother Pharmacol; 2005 Feb; 55(2):189-96. PubMed ID: 15290100
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanism(s) of antitumor action in protracted infusion of low dose 5-fluorouracil and cisplatin in gastric carcinoma.
    Kim R; Tanabe K; Inoue H; Toge T
    Int J Oncol; 2002 Mar; 20(3):549-55. PubMed ID: 11836567
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A polyethylenimine-based diazeniumdiolate nitric oxide donor accelerates wound healing.
    Zhang Y; Tang K; Chen B; Zhou S; Li N; Liu C; Yang J; Lin R; Zhang T; He W
    Biomater Sci; 2019 Mar; 7(4):1607-1616. PubMed ID: 30702089
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antisense cyclin D1 enhances sensitivity of head and neck cancer cells to cisplatin.
    Wang MB; Yip HT; Srivatsan ES
    Laryngoscope; 2001 Jun; 111(6):982-8. PubMed ID: 11404608
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synergistic antitumor activity of cisplatin and interleukin 1 in sensitive and resistant solid tumors.
    Braunschweiger PG; Basrur VS; Santos O; Markoe AM; Houdek PV; Schwade JG
    Cancer Res; 1993 Mar; 53(5):1091-7. PubMed ID: 8439953
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suicide gene therapy using E. coli beta-galactosidase.
    Farquhar D; Pan BF; Sakurai M; Ghosh A; Mullen CA; Nelson JA
    Cancer Chemother Pharmacol; 2002 Jul; 50(1):65-70. PubMed ID: 12111114
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potentiation by squalene of the cytotoxicity of anticancer agents against cultured mammalian cells and murine tumor.
    Nakagawa M; Yamaguchi T; Fukawa H; Ogata J; Komiyama S; Akiyama S; Kuwano M
    Jpn J Cancer Res; 1985 Apr; 76(4):315-20. PubMed ID: 2408954
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence of cisplatin-induced senescent-like growth arrest in nasopharyngeal carcinoma cells.
    Wang X; Wong SC; Pan J; Tsao SW; Fung KH; Kwong DL; Sham JS; Nicholls JM
    Cancer Res; 1998 Nov; 58(22):5019-22. PubMed ID: 9823301
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Probenecid is a chemosensitizer in cancer cell lines.
    Campos-Arroyo D; Martínez-Lazcano JC; Melendez-Zajgla J
    Cancer Chemother Pharmacol; 2012 Feb; 69(2):495-504. PubMed ID: 21861129
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of p53 in cisplatin-resistant ovarian cancer cell lines: modulation with the novel platinum analogue (1R, 2R-diaminocyclohexane)(trans-diacetato)(dichloro)-platinum(IV).
    Hagopian GS; Mills GB; Khokhar AR; Bast RC; Siddik ZH
    Clin Cancer Res; 1999 Mar; 5(3):655-63. PubMed ID: 10100719
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interactions of doxycycline with chemotherapeutic agents in human breast adenocarcinoma MDA-MB-231 cells.
    Foroodi F; Duivenvoorden WC; Singh G
    Anticancer Drugs; 2009 Feb; 20(2):115-22. PubMed ID: 19209028
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.